CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-05 | Puri Raj K. Chief Regulatory Officer | Option exercise | +39,059 | 257,590 | ||
| 2026-03-05 | Puri Raj K. Chief Regulatory Officer | Shares withheld for taxes | −18,360 | $4.58 | $84K | 239,230 |
| 2026-03-05 | Puri Raj K. Chief Regulatory Officer | Option exercise · Restricted Stock Units | −39,059 | 78,131 | ||
| 2026-03-05 | BILINSKY IGOR Chief Operating Officer | Option exercise | +31,246 | 142,394 | ||
| 2026-03-05 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −16,628 | $4.58 | $76K | 125,766 |
| 2026-03-05 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −31,246 | 62,504 | ||
| 2026-03-02 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +52,087 | 516,609 | ||
| 2026-03-02 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −22,809 | $3.79 | $86K | 493,800 |
| 2026-03-02 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −41,669 | 166,675 | ||
| 2026-03-02 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −10,418 | 0 | ||
| 2026-03-02 | BILINSKY IGOR Chief Operating Officer | Option exercise | +12,307 | 118,051 | ||
| 2026-03-02 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −6,903 | $3.79 | $26K | 111,148 |
| 2026-03-02 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −8,790 | 35,159 | ||
| 2026-03-02 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −3,517 | 0 | ||
| 2026-03-02 | Puri Raj K. Chief Regulatory Officer | Option exercise | +5,470 | 221,329 | ||
| 2026-03-02 | Puri Raj K. Chief Regulatory Officer | Shares withheld for taxes | −2,798 | $3.79 | $11K | 218,531 |
| 2026-03-02 | Puri Raj K. Chief Regulatory Officer | Option exercise · Restricted Stock Units | −5,470 | 21,878 | ||
| 2026-03-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +12,697 | 124,353 | ||
| 2026-03-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −7,122 | $3.79 | $27K | 117,231 |
| 2026-03-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −8,790 | 35,159 |
Page 5 of 14 · 280 trades